CME
Understanding the Fine Print: The Who, When, And What To Do About ARIA in Patients with Alzheimer’s Disease – Neurology Module
Host: James Galvin, MD, MPH, FANA Guest: Jon Toledo, MD, PhD Recently, Alzheimers Disease (AD) saw its first approvals for disease modifying therapy (DMT). With amyloid-beta (A) targeting DMT now a reality, the entire way this condition is